Vascular calcification: Lessons from scientific models

Journal of Renal Care

Volumn 35, Issue SUPPL. 1, 2009, Pages 51-56

  Sinha, Smeeta ^a   Eddington, Helen ^a   Kalra, Philip A ^a  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Basic science; Bone disease; Cardiovascular; Chronic kidney disease; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; CALCIUM BINDING PROTEIN; COLLAGEN TYPE 1; MATRIX GLA PROTEIN; OSTEOPONTIN; PHOSPHORUS; PYROPHOSPHATE; SCLEROPROTEIN; VITAMIN; VITAMIN D;

ANIMAL; APOPTOSIS; ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; DISEASE MODEL; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; MORTALITY; MOUSE; PATHOLOGY; PHYSIOLOGY; PREVALENCE; REVIEW; RISK FACTOR; VASCULAR DISEASE;

ALKALINE PHOSPHATASE; ALPHA-FETOPROTEINS; ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; CALCINOSIS; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; COLLAGEN TYPE I; DIPHOSPHATES; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MICE; OSTEOPONTIN; PHOSPHORUS; PREVALENCE; RISK FACTORS; VASCULAR DISEASES; VITAMIN D; VITAMINS;

EID: 61649097736     PISSN: 17556678     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2009.00065.x     Document Type: Review

References (37)

1. Braun J., Oldendorf M., Moshage W. et al. (1996). Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. American Journal of Kidney Disease 27, 394-401.
2. Chen N.X., O'Neill K.D., Duan D. et al. (2002). Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney International 62, 1724-1731.
3. Danziger J. (2008). Vitamin K-dependent proteins, warfarin, and vascular calcification. Clinical Journal of the American Society of Nephrology 3, 1504-1510.
4. Fleisch H. & Bisaz S. (1962). Isolation from urine of pyrophosphate, a calcification inhibitor. American Journal of Physiology 203, 671-675.
5. Fleisch H., Russell R.G. & Straumann F. (1966). Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis. Nature 212, 901-903.
6. Giachelli C.M. (2004). Vascular calcification mechanisms. Journal of American Society of Nephrology 15, 2959-2964.
7. Go A.S., Chertow G.M., Fan D. et al. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. The New England Journal of Medicine 351, 1296-1305.
8. Goodman W.G., Goldin J., Kuizon B.D. et al. (2000). Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. The New England Journal of Medicine 342, 1478-1483.
9. Hashiba H., Aizawa S., Tamura K. et al. (2006). Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients: long-term effects. Therapeutic Apheresis and Dialysis 10, 59-64.
10. Hermans M.M.H., Brandenburg V., Ketteler M. et al. (2007). Association of serum fetuin-A levels with mortality in dialysis patients. Kidney International 72, 202-207.
11. Jeziorska M., McCollum C. & Wooley D.E. (1998). Observations on bone formation and remodelling in advanced atherosclerotic lesions of human carotid arteries. Virchows Archiv 433, 559-565.
12. Jono S., Peinado C. & Giachelli C.M. (2000). Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. The Journal of Biological Chemistty 275, 20197-20203.
13. Keelan P.C., Bielak L.F., Ashai K. et al. (2001). Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation 104, 412-417.
14. Lehto S., Niskanen L., Suhonen M. et al. (1996). Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arteriosclerosis, Thrombosis, and Vascular Biology 16, 978-983.
15. Lomashvili K.A., Cobbs S., Hennigar R.A. et al. (2004). Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. Journal of American Society of Nephrology 15, 1392-1401.
16. Lomashvili K.A., Khawandi W. & O'Neill W.C. (2005). Reduced plasma pyrophosphate levels in hemodialysis patients. Journal of American Society of Nephrology 16, 2495-2500.
17. London G.M., Guerin A.P., Marchais S.J. et al. (2003). Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrology, Dialysis, Transplantation 18, 1731-1740.
18. Luo G., Ducy P., McKee M.D. et al. (1997). Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386, 78-81.
19. Mendoza F.J., Lopez I., Montes de Oca A. et al. (2007). Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney International 73, 407-414.
20. Moe S.M. & Chen N.X. (2004). Pathophysiology of vascular calcification in chronic kidney disease. Circulation Research 95, 560-567.
21. Moe S.M. & Chen N.X. (2005). Inflammation and vascular calcification. Blood Purification 23, 64-71.
22. Munroe P.B., Olgunturk R.O., Fryns J.P. et al. (1999). Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nature Genetics 21, 142-144.
23. Price P.A., Buckley J.R. & Williamson M.K. (2001). The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. Journal of Nutrition 131, 2910-2915.
24. Price P.A. & Lim J.E. (2003). The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. Journal of Biological Chemistry 278, 22144-22152.
25. Price P.A., Otsuka A.A., Poser J.W. et al. (1976). Characterization of a gamma-carboxyglutamic acid-containing protein from bone. Proceedings of the National Academy of Sciences of the United States of America 73, 1447-1451.
26. Price P.A., Faus S.A. & Williamson M.K. (2000). Warfarin-Induced Artery Calcification Is Accelerated by Growth and Vitamin D. Arteriosclerosis, Thrombosis, and Vascular Biology 20, 317-327.
27. Proudfoot D., Skepper J.N., Hegyi L. et al. (2000). Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circulation Research 87, 1055-1062.
28. Proudfoot D., Skepper J.N., Hegyi L. et al. (2001). The role of apoptosis in the initiation of vascular calcification. Zeitschrift fur Kardiologie 90(Suppl 3), 43-46.
29. Reynolds J.L., Joannides A.J., Skepper J.N. et al. (2004). Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. Journal of American Society of Nephrology 15, 2857-2867.
30. Schafer C., Heiss A., Schwarz A. et al. (2003). The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. Journal of Clinical Investigation 112, 357-366.
31. Schor A.M., Allen T.D., Canfield A.E. et al. (1990). Pericytes derived from the retinal microvasculature undergo calcification in vitro. Journal of Cell Science 97(Pt 3), 449-461.
32. Shioi A., Nishizawa Y, Jono S. et al. (1995). Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thrombosis Vascular Biology 15, 2003-2009.
33. Son B.K., Kozaki K., Iijima K. et al. (2006). Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circulation Research 98, 1024-1031.
34. Speer M.Y., McKee M.D., Guldberg R.E. et al. (2002). Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. Journal of Experimental Medicine 196, 1047-1055.
35. Tintut Y., Abedin M., Cho J. et al. (2005). Regulation of RANKL-induced osteoclastic differentiation by vascular cells. Journal of Molecular and Cellular Cardiology 39, 389-393.
36. Tintut Y., Patel J., Parhami F. et al. (2000). Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 102, 2636-2642.
37. Wolisi G.O. & Moe S.M. (2005). The role of vitamin D in vascular calcification in chronic kidney disease. Seminars in Dialysis 18, 307-314.